Clinical Trial Update: Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of quetiapine fumarate (SEROQUEL) for treating alcohol dependence in patients with bipolar I disorder; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Bipolar Disorder

Drugs mentioned

• Quetiapine fumarate (Seroquel) (quetiapine fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar I Disorder, Alcohol Dependence | Phase 3 | Status: COMPLETED